Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Comparison of FOLFIRINOX vs Gemcitabine Plus Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma.
JAMA Netw Open. 2022 Jun 1;5(6):e2216199. doi: 10.1001/jamanetworkopen.2022.16199.
JAMA Netw Open. 2022.
PMID: 35675073
Free PMC article.
Comparative Analysis of First-Line FOLFOX Treatment With and Without Anti-VEGF Therapy in Metastatic Colorectal Carcinoma: A Real-World Data Study.
Brenner R, Amar-Farkash S, Klein-Brill A, Rosenberg-Katz K, Aran D.
Brenner R, et al. Among authors: amar farkash s.
Cancer Control. 2023 Jan-Dec;30:10732748231202470. doi: 10.1177/10732748231202470.
Cancer Control. 2023.
PMID: 37724508
Free PMC article.
Item in Clipboard
Dynamic proteomics reveals bimodal protein dynamics of cancer cells in response to HSP90 inhibitor.
Zimmer A, Amar-Farkash S, Danon T, Alon U.
Zimmer A, et al. Among authors: amar farkash s.
BMC Syst Biol. 2017 Mar 7;11(1):33. doi: 10.1186/s12918-017-0410-8.
BMC Syst Biol. 2017.
PMID: 28270142
Free PMC article.
Item in Clipboard
Cite
Cite